Michael Tankersley, MD
Allergy & Immunology · Collierville, TNNPI 1114997814
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,250 of the $61,424 with a category attached, or 65.5%. Alk-abello, Inc accounts for 77.9% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2022 at $19,615 and has fallen 95.5% since, to $889 in 2025.
Across 441 payments — averaging $139.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alk-abello, Inc$48K
- Jubilant Hollisterstier LLC$5K
- Sanofi$2K
- AstraZeneca$2K
- Pfizer$1K
- GSK$1K
- plus $3K from 23 others
What the payments were for
- Consulting fees$9,50015%
- Speaking & faculty fees$40,25066%
- Grants$1,0002%
- Travel & lodging$1,6293%
- Food & beverage$8,93315%
- Education$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alk-abello, Inc | 78 | $47,821 |
| Jubilant Hollisterstier LLC | 1 | $4,600 |
| Sanofi | 42 | $1,885 |
| AstraZeneca | 62 | $1,719 |
| Pfizer | 76 | $1,456 |
| GSK | 60 | $1,328 |
| Genentech USA, Inc. | 33 | $827 |
| Kaleo, Inc. | 25 | $465 |
| Novartis | 9 | $133 |
| Octapharma USA, Inc. | 2 | $132 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $123 |
| Merck | 6 | $99 |
| Optinose US, Inc. | 5 | $94 |
| Teva Pharmaceuticals USA, Inc. | 5 | $92 |
| Aimmune Therapeutics, Inc. | 3 | $91 |
| LEO Pharma Inc. | 5 | $82 |
| Grifols USA, LLC | 5 | $71 |
| Verona Pharma, Inc. | 3 | $65 |
| Galderma Laboratories, L.p. | 2 | $46 |
| Eyevance Pharmaceuticals LLC | 2 | $42 |
| CSL Behring | 2 | $42 |
| Pharming Healthcare, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Cycle Pharmaceuticals Inc | 1 | $30 |
| Hikma Pharmaceuticals USA | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Amgen | 1 | $23 |
| Incyte Corporation | 1 | $21 |
| Shire North American Group Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$61,424 in reported general payments places this provider in the 85th percentile of 79 allergy & immunology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 18 | $18,240 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 38 | $8,321 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 33 | $2,261 |
| Ipratropium Bromide | 39 | $1,730 |
| Azelastine Hcl | 53 | $1,623 |
| Fluticasone Propionate | 74 | $1,251 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $568 |
| Montelukast Sodium | 16 | $225 |
| Famotidine | 15 | $187 |
| Prednisone | 16 | $26 |
| Amoxicillin | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Shingrix | $1,328 | $26,56156 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 79 allergy & immunology providers in Tennessee.
Other allergy & immunology in Collierville
- Nicholas KolinskyKnoxville$472K
- Tidence PrinceMaryville$269K
- Tammy Heinly McCulleyGermantown$165K
- Phillip LiebermanMemphis$131K
- John FahrenholzNashville$124K
- Marc CromieChattanooga$106K
- Reena PatelMemphis$101K
- Jay LiebermanMemphis$81K
- Katherine CahillNashville$73K
- Todd LevinChattanooga$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.